Reproduction-related Risk Factors for Mucinous and Nonmucinous
... among cases with mucinous cancer than among other cases. The protective effects for parity were also smaller in the mucinous group, albeit not significantly so. Differences between the mucinous and nonmucinous groups with respect to hysterectomy, tubal sterilization, and breastfeeding were not signi ...
... among cases with mucinous cancer than among other cases. The protective effects for parity were also smaller in the mucinous group, albeit not significantly so. Differences between the mucinous and nonmucinous groups with respect to hysterectomy, tubal sterilization, and breastfeeding were not signi ...
Acne Vulgaris Guidelines
... tazarotene). Used at bedtime. Can be irritating. Start every other night and titrate up. Topical antibiotic agents such as clindamycin, benzoyl peroxide/clindamycin, sodium sulfacetamide, azelaic acid, salicylic acid BID are useful for inflammatory lesions To prevent bacterial resistance use benzoyl ...
... tazarotene). Used at bedtime. Can be irritating. Start every other night and titrate up. Topical antibiotic agents such as clindamycin, benzoyl peroxide/clindamycin, sodium sulfacetamide, azelaic acid, salicylic acid BID are useful for inflammatory lesions To prevent bacterial resistance use benzoyl ...
Typical disorders of the endocrine system 1. Choose the correct
... c) violation of circadian rhythms "wakefulness - sleep"; d) development of myxedema; e) diffuse toxic goiter. 24. Hyperproduction of glucocorticoids causes a) hypoglycemia; b) a positive nitrogen balance; + c) increase in blood pressure; d) increased bone ossification; e) lowering the excitability o ...
... c) violation of circadian rhythms "wakefulness - sleep"; d) development of myxedema; e) diffuse toxic goiter. 24. Hyperproduction of glucocorticoids causes a) hypoglycemia; b) a positive nitrogen balance; + c) increase in blood pressure; d) increased bone ossification; e) lowering the excitability o ...
Endocrine System
... During childhood, ovaries grow and secrete small amounts of estrogens that inhibit the hypothalamic release of GnRH As puberty nears, GnRH is released; FSH and LH are released by the pituitary, which act on the ovaries These events continue until an adult cyclic pattern is achieved and menarche ...
... During childhood, ovaries grow and secrete small amounts of estrogens that inhibit the hypothalamic release of GnRH As puberty nears, GnRH is released; FSH and LH are released by the pituitary, which act on the ovaries These events continue until an adult cyclic pattern is achieved and menarche ...
Androgen receptor CAG repeat length is associated with ovarian
... two of the following three features must be present: advanced maternal age or any other risk factor for poor ovarian response; a previous poor ovarian response; and an abnormal ovarian reserve test (Ferraretti et al., 2011). About 9–24% of women undergoing IVF respond more poorly than expected to th ...
... two of the following three features must be present: advanced maternal age or any other risk factor for poor ovarian response; a previous poor ovarian response; and an abnormal ovarian reserve test (Ferraretti et al., 2011). About 9–24% of women undergoing IVF respond more poorly than expected to th ...
Can Elevated Levels of Basal Follicle Stimulating
... correlate significantly with FSH levels (group3 vs 4). This means that older women have small size follicular pool with impaired quality. The aging follicles do not respond to even high doses of gonadotropins. Our study shows that women aged ≥ 38 years with FSH ≥ 9.6IU/l (group4), provide the poores ...
... correlate significantly with FSH levels (group3 vs 4). This means that older women have small size follicular pool with impaired quality. The aging follicles do not respond to even high doses of gonadotropins. Our study shows that women aged ≥ 38 years with FSH ≥ 9.6IU/l (group4), provide the poores ...
abnormalities of pubertal development and fertility risk in adolescents
... . there is a high incidence of delayed puberty and primary amenorrhea in girls with anorexia nervosa and in girls who are highly competitive athletes. These girls have hypogonadotropic hypogonadism that appears to be directly related to their low body fat. Girls with a low body mass index (BMI) a ...
... . there is a high incidence of delayed puberty and primary amenorrhea in girls with anorexia nervosa and in girls who are highly competitive athletes. These girls have hypogonadotropic hypogonadism that appears to be directly related to their low body fat. Girls with a low body mass index (BMI) a ...
13 Physiologicoanatomical peculiarities of endocrine system
... reproductive organs found in female organisms. They are part of the vertebrate female reproductive system. Ovaries in females are homologous to testes in males. The term gonads refers to the ovaries in females and testes in ...
... reproductive organs found in female organisms. They are part of the vertebrate female reproductive system. Ovaries in females are homologous to testes in males. The term gonads refers to the ovaries in females and testes in ...
Endocrine SystemExam
... 9. This is the gland that regulates the levels of calcium in the bloodstream: a. A b. D c. C d. B 10. Testosterone is secreted by this gland: a. H b. G c. A d. F 11. The gland found in the brain that “connects” the nervous system and the endocrine system is called the: a. Parathyroid b. Thyroid c. ...
... 9. This is the gland that regulates the levels of calcium in the bloodstream: a. A b. D c. C d. B 10. Testosterone is secreted by this gland: a. H b. G c. A d. F 11. The gland found in the brain that “connects” the nervous system and the endocrine system is called the: a. Parathyroid b. Thyroid c. ...
effect of metformin on thyroid stimulating hormone in euthyroid type
... KEYWORDS: Metformin Thyroid Stimulating Hormone Type 2 Diabetes Thyroid dysfunction. INTRODUCTION: Metformin is a first line drug in the treatment of type 2 diabetes mellitus.(1) It is shown to protect against long term cardiovascular morbidity and mortality, apart from controlling blood glucose in ...
... KEYWORDS: Metformin Thyroid Stimulating Hormone Type 2 Diabetes Thyroid dysfunction. INTRODUCTION: Metformin is a first line drug in the treatment of type 2 diabetes mellitus.(1) It is shown to protect against long term cardiovascular morbidity and mortality, apart from controlling blood glucose in ...
THE NATIONAL LUPRON VICTIMS NETWORK
... Ammenorrhea (loss of your menstruation) can be due to four different causes: 1. disorders of the pituitary gland; 2. disorders of the hypothalamus and central nervous system; ...
... Ammenorrhea (loss of your menstruation) can be due to four different causes: 1. disorders of the pituitary gland; 2. disorders of the hypothalamus and central nervous system; ...
NLVN Factsheet - Lupron Victims Hub
... Ammenorrhea (loss of your menstruation) can be due to four different causes: 1. disorders of the pituitary gland; 2. disorders of the hypothalamus and central nervous system; ...
... Ammenorrhea (loss of your menstruation) can be due to four different causes: 1. disorders of the pituitary gland; 2. disorders of the hypothalamus and central nervous system; ...
Sex Hormone Bind ing Globulin: The Connection between
... The androgen sex hormone, testosterone, by itself or relative to estrogen levels, may be a relative risk factor for CVD in women.11 Exogenous testosterone may negate the benefits of ERT12, and metabolic states with high testosterone or testosterone precursors are associated with increased cardiovasc ...
... The androgen sex hormone, testosterone, by itself or relative to estrogen levels, may be a relative risk factor for CVD in women.11 Exogenous testosterone may negate the benefits of ERT12, and metabolic states with high testosterone or testosterone precursors are associated with increased cardiovasc ...
Evaluation of Abnormal Uterine Bleeding
... After ovulation the corpus luteum forms from the ruptured site in the ovary “yellow body” FSH and LH cause remaining parts of the dominant follicle to form the corpus luteum Corpus luteum produces progesterone Progesterone causes endometrial changes to facilitate implantation of an embryo and raises ...
... After ovulation the corpus luteum forms from the ruptured site in the ovary “yellow body” FSH and LH cause remaining parts of the dominant follicle to form the corpus luteum Corpus luteum produces progesterone Progesterone causes endometrial changes to facilitate implantation of an embryo and raises ...
File
... • With diabetes mellitus, either your body doesn't make enough insulin, it can't use the insulin it does produce, or a combination of both. ...
... • With diabetes mellitus, either your body doesn't make enough insulin, it can't use the insulin it does produce, or a combination of both. ...
Hormonal preparations
... intravenously dropply counting 0,1 ОD/kg of body weight per hour. First two hours – with the speed of 8 ОD/hour. If the initial glycemia is higher than 33,3 mmol/lл insulin dose in first hour is increased till 16 OD. In case of decreasing of sugar level on 25-50 % from the initial level the speed of ...
... intravenously dropply counting 0,1 ОD/kg of body weight per hour. First two hours – with the speed of 8 ОD/hour. If the initial glycemia is higher than 33,3 mmol/lл insulin dose in first hour is increased till 16 OD. In case of decreasing of sugar level on 25-50 % from the initial level the speed of ...
Home-work-sheet
... 4. The hormone which its deficiency causes the enlargement of the thyroid gland is ------------. (Estrogen – insulin – thyroxin – glucagon) 5. The hormone which stimulates the storage of glucose sugar in liver is the --------------. (Estrogen – insulin – thyroxin – glucagon) 6. The hormone which reg ...
... 4. The hormone which its deficiency causes the enlargement of the thyroid gland is ------------. (Estrogen – insulin – thyroxin – glucagon) 5. The hormone which stimulates the storage of glucose sugar in liver is the --------------. (Estrogen – insulin – thyroxin – glucagon) 6. The hormone which reg ...
Endocrine Drugs - My Illinois State
... If the patient’s cortisol level is augmented by 6 mcg per dL and the peak cortisol level is > 20 mcg per dL, the HPA axis has recovered and exogenous steroid can safely be discontinued If the increase in cortisol is < 6 mcg per dL and/or the peak cortisol value is < 20 mcg per dL, a slower stero ...
... If the patient’s cortisol level is augmented by 6 mcg per dL and the peak cortisol level is > 20 mcg per dL, the HPA axis has recovered and exogenous steroid can safely be discontinued If the increase in cortisol is < 6 mcg per dL and/or the peak cortisol value is < 20 mcg per dL, a slower stero ...
dhea in poor responders
... • Treating SLE- Increased E2 and reduced DHEAS levels in lupus patients may help induce cytokine abnormalities early in disease ...
... • Treating SLE- Increased E2 and reduced DHEAS levels in lupus patients may help induce cytokine abnormalities early in disease ...
The Endocrine System
... Diabetes Type II-insulin is secreted in small amounts; 90-95% of diabetics have this type. Compare Type I to Type II diabetes-Type II is more common in adults over 45, overweight, family history, certain ethnic or cultural groups *TREATMENT: Insulin (oral or injections), diet ...
... Diabetes Type II-insulin is secreted in small amounts; 90-95% of diabetics have this type. Compare Type I to Type II diabetes-Type II is more common in adults over 45, overweight, family history, certain ethnic or cultural groups *TREATMENT: Insulin (oral or injections), diet ...
Dr. AASHISH H. PANCHAL (M.PHARM., Ph.D.) GSEB, CBSE, ICSE
... CHAPTER-2 Endocrine System Marks:40 ...
... CHAPTER-2 Endocrine System Marks:40 ...
Normal pituitary Magnetic resonance scan
... TRH/TSH (Thyrotropin; recombinant human TSH (THYROGEN) Not commonly used to treat thyroid disorders but are used to distinguish between hypothalamic-pituitary-thyroid gland dysfunction. ...
... TRH/TSH (Thyrotropin; recombinant human TSH (THYROGEN) Not commonly used to treat thyroid disorders but are used to distinguish between hypothalamic-pituitary-thyroid gland dysfunction. ...
Canadian Product Monograph
... administration is permanent. Age of initiation of treatment: various ages ranging from early childhood to immediately before expected puberty have been suggested. On the average, however, 12 years appears to be the appropriate age. ...
... administration is permanent. Age of initiation of treatment: various ages ranging from early childhood to immediately before expected puberty have been suggested. On the average, however, 12 years appears to be the appropriate age. ...
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS), also called hyperandrogenic anovulation (HA), or Stein–Leventhal syndrome, is a set of symptoms due to a hormone imbalance in women. Signs and symptoms of PCOS include irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, trouble getting pregnant, and patches of thick, darker, velvety skin. Associated conditions include type 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, and endometrial cancer.PCOS is due to a combination of genetic and environmental factors. Risk factors include obesity, not enough physical exercise, and a family history of someone with the condition. Diagnosis is based on two of the following three findings: no ovulation, high androgen levels, and ovarian cysts. Cysts may be detectable by ultrasound. Other conditions that produce similar symptoms include adrenal hyperplasia, hypothyroidism, and hyperprolactinemia.PCOS has no cure. Treatment may involve lifestyle changes such as weight loss and exercise. Birth control pills may help with improving the regularity of periods, excess hair, and acne. Metformin and anti-androgens may also help. Other typical acne treatments and hair removal techniques may be used. Efforts to improve fertility include weight loss, clomiphene, or metformin. In vitro fertilization is used by some in whom other measures are not effective.PCOS is the most common endocrine disorder among women between the ages of 18 and 44. It affects approximately 5% to 10% of this age group. It is one of the leading causes of poor fertility. The earliest known description of what is now recognized as PCOS dates from 1721 in Italy.